Amarin Community

NasdaqCM:AMRN Community

1 Narratives written by author
1 Comments on narratives written by author
11 Fair Values set on narratives written by author

AN

AnalystConsensusTarget

Consensus Narrative from 2 Analysts

I Foresee 49 Approvals Driving European And Global Market Expansion

Key Takeaways Expanded regulatory approvals and commercialization in 49 markets support future revenue growth, particularly through focused expansion in Europe and worldwide. Strong intellectual property and financial stability underpin strategic marketing, expected to enhance revenue and profitability, especially for VASCEPA in high-risk cardiovascular populations.

US$13.50

FV

22.5% undervalued

-1.94%

Revenue growth p.a.

0

0

10

6 days ago